63421-71-6 Usage
General Description
4-{[(4-nitrophenyl)sulfonyl]amino}benzoic acid is a chemical compound that belongs to the class of benzoic acids. It consists of a benzene ring with a carboxylic acid group and an amine group, as well as a sulfonamide group attached to the aromatic ring. The compound is often used as a building block in the synthesis of other organic compounds, and it has potential applications in pharmaceuticals and agrochemicals. The presence of the nitro and sulfonamide groups makes this compound useful in medicinal chemistry, as it can interact with biological systems in a specific and targeted manner. Additionally, the compound's structure and reactivity make it suitable for various chemical reactions and transformations in organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 63421-71-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,4,2 and 1 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 63421-71:
(7*6)+(6*3)+(5*4)+(4*2)+(3*1)+(2*7)+(1*1)=106
106 % 10 = 6
So 63421-71-6 is a valid CAS Registry Number.
63421-71-6Relevant articles and documents
-
Magerlein,Weisblat
, p. 1702 (1954)
-
Bio-potent sulfonamides
Dineshkumar, Selvakumar,Thirunarayanan, Ganesamoorthy
, p. 4386 - 4391 (2019/06/27)
Some 4-(substituted phenylsulfonamido)benzoic acids have been synthesized by fly-ash:H3PO3 nano catalyst catalyzed condensation of substituted benzenesulfonyl chlorides and 4-aminobenzoic acid in ultrasound irradiation conditions. The yields of the sulfonamides are more than 90%. The synthesized 4-(substituted phenylsulfonamido) benzoic acid derivatives were characterized by their physical constants, analytical and spectroscopic data. Antimicrobial activities of all sulfonamides were measured by Bauer-Kirby disc diffusion method.
Inhibitors of Histone Deacetylase
-
Page/Page column 15, (2010/11/29)
The present invention relates to hydroxamic acid derivatives that are inhibitors of histone deacetylase (HDAC). The compounds of the present invention are useful for treating cellular proliferative diseases, including cancer. Further, the compounds of the
